RxSight, Inc. (RXST) Tops Q3 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts RXST Hot Sheet
Join SI Premium – FREE
RxSight, Inc. (NASDAQ: RXST) reported Q3 EPS of ($0.21), $0.08 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $24.6 million versus the consensus estimate of $27.19 million.
For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RxSight Inc. (RXST) PT Lowered to $5 at Stifel
- United Therapeutics Corp. (UTHR) PT Raised to $768 at BTIG
- Oppenheimer Downgrades Fidelity National Information Services (FIS) to Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
